University of Washington’s François Baneyx has sealed the job of vice-provost for innovation having administered the same duties as caretaker since February last year.

Verily has taken part in an oversubscribed series B round that will fund the UC Berkeley spinout's expansion from diagnostics to gene editing and drug development.

The online pharmacy is set to announce a series D round that will be led by $250m from SoftBank Vision Fund at a valuation in excess of $1bn.

The GV-backed primary care membership service floated at the bottom of its range but garnered a valution of more than $1.7bn.

Alphabet unit Verily has taken part in an oversubscribed series B round that will fund Mammoth Biosciences' expansion from diagnostics to gene editing and drug development.

Waters Corporation reinvested in the protein characterisation technology producer through an oversubscribed round that will fund innovation and expansion.

Saint Louis University spinout BioIntervene will use the capital to fund phase 1 trials for its non-addictive painkillers later this year.

The university formed 23 new spinouts in 2019, while a total of 33 companies raised a combined $292m – an amount only beaten by 2016’s record-holding $408m.

Wuxi AppTec and Alphabet are in line to exit the molecule-discovery software provider, which has set the range for its initial public offering.

AbbVie Ventures took a board seat through its contribution to the round, closed as the inflammatory disease therapy developer emerged from stealth.